SBC Medical Group Joins Russell 3000 Index and Appoints New CMO

SBC Medical Group Holdings Inc. has been added to the Russell 3000® Index, marking a significant milestone for the company as it gains visibility among a broader base of investors. This inclusion, effective as of June 30, 2025, not only enhances the company's profile but also serves as a validation of its relevance and growth in the economy. The Russell indexes are a benchmark for about $18.1 trillion in assets globally, with $10.6 trillion in the U.S. alone, making this a pivotal moment for SBC Medical Group.

In addition to its index inclusion, SBC Medical Group has announced the appointment of Shinya Inoue as its new Chief Marketing Officer. Inoue's extensive experience in brand strategy and digital marketing is expected to drive the company's global expansion and brand elevation. His previous roles at Pioneer Corporation, P&G Japan, Eli Lilly Japan, Adobe, and KDDI underscore his capability to lead marketing initiatives and organizational development.

The company's recent achievements, including a 5% year-over-year increase in earnings per share and a rise in EBITDA margins to 52%, reflect its strong performance in the cosmetic surgery market. With 251 clinics and a significant portion of customers returning for multiple visits, SBC Medical Group is well-positioned for continued growth in Japan and internationally.